We conclude that HFD induced obesity in C57BL/6 mice can lead to the occurrence of OA, and oral resveratrol may alleviate OA pathology by decreasing the levels of cytokines and/or through inhibiting TLR4/TRAF6 signaling pathways. The gene discussed is TRAF6; the disease is obesity due to melanocortin 4 receptor deficiency.